John Huntinghouse

A Randomized and Clinical Effectiveness Trial Comparing Two Pharmacogenetic Algorithms and Standard Care for Individualizing Warfarin Dosing (CoumaGen-II)

Jeffrey L. Anderson, Benjamin D. Horne, Scott M. Stevens et al. · Circulation · 2012 · 231 citations

Shortened telomere length is associated with paroxysmal atrial fibrillation among cardiovascular patients enrolled in the Intermountain Heart Collaborative Study

John F. Carlquist, Stacey Knight, Richard Cawthon et al. · Heart Rhythm · 2015 · 46 citations · Full text

Cardiovascular Disease, Paroxysmal Atrial Fibrillation, Telomere Length +7

An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose prediction

John F. Carlquist, Benjamin D. Horne, Chrissa P. Mower et al. · Journal of Thrombosis and Thrombolysis · 2010 · 37 citations

Thrombosis, Genetic Variants, Medicine +10

A Possible Mechanistic Link Between the CYP2C19 Genotype, the Methadone Metabolite Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidene (EDDP), and Methadone-Induced Corrected QT Interval Prolongation in a Pilot Study

John F. Carlquist, David E. Moody, Stacey Knight et al. · Molecular Diagnosis & Therapy · 2015 · 29 citations

Methadone Metabolite Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidene, Substance Abuse, Cyp2c19 Genotype +9

Validation and Quantification of Genetic Determinants of Lipoprotein-a Levels and Predictive Value for Angiographic Coronary Artery Disease

Jeffrey L. Anderson, Stacey Knight, Heidi T. May et al. · The American Journal of Cardiology · 2013 · 13 citations

Genetics, Genetic Epidemiology, Predictive Value +16